Patent · US Active

HIV protease inhibiting compounds

US8653141B2 · kind B2 · utility

0Cited by
5References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 19, 2012
Grant dateFeb 18, 2014
Priority date—
Expiry dateApr 19, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D493/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of the formulais disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.